A rationally designed nanoparticle for RNA interference therapy in B-lineage lymphoid malignancies

Keyphrases

• Nanoparticles 100%
• Small Interfering RNA (siRNA) 100%
• Rationally Designed 100%
• Lymphoid Malignancies 100%
• B-lineage 100%
• RNA Interference Therapy 100%
• RNA Interference 66%
• BPL Cell 66%
• Molecular Targets 33%
• Cell Growth 33%
• Polypeptide 33%
• Further Development 33%
• Effective Treatment 33%
• SiRNA Knockdown 33%
• Genetic Defects 33%
• High Risk 33%
• Cargo 33%
• High Incidence 33%
• Nanoparticle Formulation 33%
• Pediatric 33%
• Therapeutic Innovation 33%
• Chemotherapy Resistance 33%
• Molecular Lesions 33%
• Leukemia Cells 33%
• Therapeutic Candidates 33%
• Clonogenicity 33%
• Causal Link 33%
• Nanoformulation 33%
• RNA Therapeutics 33%
• Leukemic Cells 33%

Medicine and Dentistry

• Nanoparticle 100%
• Small Interfering RNA 100%
• RNAi Therapeutics 100%
• Lymphoma 100%
• Cell Growth 25%
• Polypeptide 25%
• Pediatrics 25%
• Genetic Disorder 25%
• Leukemia Cell 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Small Interfering RNA 100%
• Nanoparticle 100%
• Lymphoma 100%
• Polypeptide 25%
• Chemotherapy 25%
• Genetic Disorder 25%
• Molecular Target 25%
• Leukemia 25%